These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3585720)

  • 1. Dosage intervals based on mean residence times.
    Wagner JG
    J Pharm Sci; 1987 Jan; 76(1):35-8. PubMed ID: 3585720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generalized equations for multiple dose kinetics by i.v. injection.
    Hajratwala BR
    Pharmazie; 1976; 31(10):731-3. PubMed ID: 1019197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.
    Cheng H; Jusko WJ
    Pharm Res; 1990 Jun; 7(6):628-32. PubMed ID: 2367330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Loo-Riegelman absorption method.
    Wagner JG
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):51-67. PubMed ID: 1127578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.
    Slattery JT
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):105-10. PubMed ID: 7381689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.
    Chen HS; Gross JF
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):117-25. PubMed ID: 458554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of queueing theory to pharmacokinetics.
    Brill PH; Moon RE
    J Pharm Sci; 1980 May; 69(5):558-60. PubMed ID: 7381743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for controlled establishment of steady-state plasma levels through multiple dosing.
    Weiss M; Förster W
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):102-4. PubMed ID: 649225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphical approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Macheras PE
    J Pharm Sci; 1985 May; 74(5):582-4. PubMed ID: 4020640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pocket calculator program for pharmacokinetic dosing of drugs exhibiting single compartment first-order elimination and zero-order or first-order absorption.
    Hochstrasser DF; Fleck RJ; Hull JH; Sarubbi FA
    Comput Biomed Res; 1984 Feb; 17(1):27-37. PubMed ID: 6546538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The single-point method of dosage prediction: pharmacokinetic basis and method optimization.
    Love BL; Tsuei SE; Thomas J; Nation RL
    Biopharm Drug Dispos; 1982; 3(3):191-201. PubMed ID: 7139060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.